These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15989030)

  • 1. [Systemic approach to investigation of levitra efficacy in patients with chronic prostatitis with erectile dysfunction].
    Aliaev IuG; Ronkin MA; Esilevskiĭ IuM; Zhuchenko TD; Demidko IuL; Krupinov GE; Shcherbanina VIu
    Urologiia; 2005; (2):53-60. PubMed ID: 15989030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Levitra in the treatment of patients with chronic prostatitis associated with sexual dysfunction].
    Esilevskiĭ IuM; Aliaev IuG; Krupinov GE; Zhuchenko TD; Akhvlediani ND
    Urologiia; 2006; (6):18-22. PubMed ID: 17315706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Levitra (vardenafil)--a new PDE 5 inhibitor for the treatment of erectile dysfunction].
    Katsarov M
    Akush Ginekol (Sofiia); 2004; 43 Suppl 1():31-2. PubMed ID: 15323315
    [No Abstract]   [Full Text] [Related]  

  • 4. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy.
    Nehra A; Grantmyre J; Nadel A; Thibonnier M; Brock G
    J Urol; 2005 Jun; 173(6):2067-71. PubMed ID: 15879836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and safety of treatment of erectile dysfunction with Vardenafil under routine conditions].
    Van Ahlen H; Zumbé J; Stauch K; Landen H
    MMW Fortschr Med; 2005 Oct; 147(43):41. PubMed ID: 16302421
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effective and safe use of Levitra (Vardenafil) for treatment of erectile dysfunction].
    Mazo EB; Gamidov SI; Ovchinnikov RI
    Urologiia; 2004; (3):58-66. PubMed ID: 15199819
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy and tolerability of vardenafil within the time window of 6 hours after administration and beyond].
    Porst H; Lunglmayr G;
    MMW Fortschr Med; 2005 May; 147(18):43. PubMed ID: 15934588
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral drug treatment of erectile dysfunction.
    Int J Impot Res; 2003 Dec; 15 Suppl 7():S27-9. PubMed ID: 14695970
    [No Abstract]   [Full Text] [Related]  

  • 9. Vardenafil improves erectile function in men with erectile dysfunction irrespective of disease severity and disease classification.
    Donatucci C; Eardley I; Buvat J; Gittelman M; Kell P; Segerson T; Homering M; Montorsi F;
    J Sex Med; 2004 Nov; 1(3):301-9. PubMed ID: 16422960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase 5 inhibitors for erectile dysfunction.
    Setter SM; Iltz JL; Fincham JE; Campbell RK; Baker DE
    Ann Pharmacother; 2005; 39(7-8):1286-95. PubMed ID: 15941818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-titration of vardena fi l dose from 10 mg to 20 mg improved erectile function in men with spinal cord injury.
    Kimoto Y; Sakamoto S; Fujikawa K; Tachibana T; Yamamoto N; Otani T
    Int J Urol; 2006 Nov; 13(11):1428-33. PubMed ID: 17083398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New PDE-5 inhibitor for treatment of impotence. 9 out of 10 have erections again].
    MMW Fortschr Med; 2003 Jun; 145(26):59. PubMed ID: 12916343
    [No Abstract]   [Full Text] [Related]  

  • 13. Vardenafil (levitra) for erectile dysfunction.
    Med Lett Drugs Ther; 2003 Sep; 45(1166):77-8. PubMed ID: 14506469
    [No Abstract]   [Full Text] [Related]  

  • 14. Visual field defect and intracerebral hemorrhage associated with use of vardenafil (Levitra).
    Hellstrom WJ
    Neurology; 2006 Jan; 66(2):293-4; author reply 293-4. PubMed ID: 16434684
    [No Abstract]   [Full Text] [Related]  

  • 15. Prescribing all phosphodiesterase 5 inhibitors to a patient with erectile dysfunction--a realistic and feasible option in everyday clinical practice--outcomes of a simple treatment regime.
    Ströberg P; Hedelin H; Ljunggren C
    Eur Urol; 2006 May; 49(5):900-7; discussion 907. PubMed ID: 16564126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDE-5 inhibitors: current status and future trends.
    Masson P; Lambert SM; Brown M; Shabsigh R
    Urol Clin North Am; 2005 Nov; 32(4):511-25, viii. PubMed ID: 16291042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual loss with erectile dysfunction medications.
    Wooltorton E
    CMAJ; 2006 Aug; 175(4):355. PubMed ID: 16870715
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit.
    Firoozi F; Longhurst PA; White MD
    BJU Int; 2005 Jul; 96(1):164-8. PubMed ID: 15963142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levitra for sphincter of Oddi dysfunction? Are you kidding?
    Affronti J
    Gastrointest Endosc; 2009 May; 69(6):1117-9. PubMed ID: 19410043
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic efficacy of a course administration of vardenafil--inhibitor of phosphodiesterase-5--in erectile dysfunction].
    Aliaev IuG; Vinarov AZ; Akhvlediani ND
    Urologiia; 2007; (1):45-6, 49. PubMed ID: 17471999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.